Zecca, C., Disanto, G., Mühl, S., & Gobbi, C. (2017). Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: The CORE study. BMC neurology, 17(1), 171-5. https://doi.org/10.1186/s12883-017-0952-9
Chicago-Zitierstil (17. Ausg.)Zecca, Chiara, Giulio Disanto, Sarah Mühl, und Claudio Gobbi. "Subjective Patient-reported Versus Objective Adherence to Subcutaneous Interferon β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study." BMC Neurology 17, no. 1 (2017): 171-5. https://doi.org/10.1186/s12883-017-0952-9.
MLA-Zitierstil (9. Ausg.)Zecca, Chiara, et al. "Subjective Patient-reported Versus Objective Adherence to Subcutaneous Interferon β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study." BMC Neurology, vol. 17, no. 1, 2017, pp. 171-5, https://doi.org/10.1186/s12883-017-0952-9.